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p¼0.006).
Conclusions: Genetically elevated Lp(a) level is causally associated with
CAVS, independently of CAD. First-degree relatives of patients with CAVS




GENETIC RISK LOCI FOR AAA ARE ASSOCIATED WITH INFLAMMATORY
BIOMARKERS WITHIN THE ANEURYSM-EXPRESS BIOBANK STUDY
C. Van Laarhoven 1, D.P. de Kleijn 1, J.A. van Herwaarden 1, G.J. de
Borst 1, S.W. van der Laan 2. 1University Medical Center Utrecht, Vascular
Surgery, Utrecht, The Netherlands; 2University Medical Center Utrecht,
Laboratory of Experimental Cardiology, Utrecht, The Netherlands
Background and Aims: Abdominal aortic aneurysms (AAA) have a
multifactorial pathology with both genetic and environmental risk factors.
Genome-wide association studies have discovered nine genetic risk loci for
AAA. Our aim was to investigate to what extent these genetic variants
contribute to the aneurysm pathology.
Methods: The nine risk variants for AAA were selected for analysis. Indi-
vidual variants and a weighted genetic risk score (GRS) were tested for
association with eight inflammatory biomarkers (IL-6,IL-8,MMP-8,MMP-
9,MCP-1,IFN-gamma,TNF-alpha, and -beta) in AAA tissue from the Aneu-
rysm-Express Biobank Study cohort. In total 220 tissue samples were
included.We correctedmodels for age, sex, ancestral background, smoking
status and maximum diameter of the aneurysm sac, and data was
normalized.
Results: For one variant (rs10757274, A>G on 9p21), a nominal association
with IFN-gamma was found (b ¼ 0.216 pg/mL ± se 0.108, per A-allele,
p¼0.048, effect allele frequency ¼ 0.485). Another variant (rs10985349,
C>T on 9q33.2) was nominally associated with MCP-1 (b ¼ -0.296 ± se
0.133, per T-allele, p¼0.028, effect allel frequency ¼ 0.232), and the var-
iant(rs6511720, G>T) on 19p13.2 with IL-8 (b ¼ -0.424 ± se 0.189, per T-
allele, p¼0.026, effect allele frequency¼ 0.096). The GRS based on the nine
risk variants showed no significant correlation with the studied
biomarkers.
Conclusions: Within our AAA cohort, three risk loci
(rs10757274,rs10985349,rs6511720) were nominally associated with IFN-
gamma, MCP-1 and IL-8 respectively. Given the limited sample size, these
results require validation within future biobank collaborations to assess
the potential causal role of these genetic risk variants in the inflammatory
pathology of AAA.
Workshop track 1
Workshop: Lipoproteins and Immunity
EAS19-0579.
B CELL UPTAKE OF MODIFIED LDL RESULTS IN MODULATION OF B CELL
ACTIVATION AND FUNCTIONS
T. Waseem Wassem 1, C. Keeter 1, A. Moriarty 2, C. Fernandez-
Hernando 3, E. Galkina 2. 1 Eastern Virginia Medical School, Microbiology,
Norfolk, USA; 2 EVMS, Microbiology, Norfolk, USA; 3 Yale Medical School,
Departments of Comparative Medicine and Pathology, New Haven, USA
Background and Aims: Uptake of mLDL by macrophages are key events in
atherosclerosis. Our data shows that B cells can also uptake mLDL. The
focus of this study is to determine the role of mLDL uptake in B cell biology.
Methods: To test a T-independent immune response, BDDhcr24 cells and
BWT cells were adoptively transferred in B cell deficient mice that were
immunized with DNP-Ficoll. To measure intracellular calcium changes, B
cells were preincubated with Fluo3, activated with IgM F(ab’)2, and cal-
cium changes were measured via FACS.
Results: Upon mLDL uptake, B cells dampen activating signaling molecule
such as SYK, ERK, and BTK, but upregulate inhibitory molecules such asphospho-Lyn (Tyr507). mLDL+ B cells mobilize less intracellular calcium
upon BCR cross-linking. B cells are also less efficient in response to DNP-
Ficoll immunization upon mLDL uptake. Uptake of mLDL by macrophages
activate LXR target genes and suppresses inflammation via the accumu-
lation of the cholesterol intermediate desmosterol. To test a role of des-
mosterol in B cells we used transgenic mice overexpressing 3b-
Hydroxysterol D24-reductase (Dhcr24). The elevated expression of Dhcr24
resulted in reduced desmosterol levels in B cells. There was a significant
increase in genes in the cholesterol efflux pathway such as Abca1 and
Abcg1 in BDDhcr24 vs BWT cells. BDDhcr24 cells mobilized more intra-
cellular calcium in response to BCR cross-linking. Functionally, adoptively
transferred BDDhcr24 cells generated a more efficient response to DNP-
Ficoll.
Conclusions: Thus, mLDL uptake by B cells likely via desmosterol accu-
mulation plays an anti-inflammatory role through the regulation of B cell
activation and functions in atherosclerosis.
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HYPERCHOLESTEROLEMIA PROMOTES A MAST CELL-CD4+ T-CELL
INTERACTION IN ATHEROSCLEROSIS
I. Bot 1, E. Kritikou 1, T. van der Heijden 1, M. Swart 1, J. van Duijn 1, B.
Slütter 1, A. Wezel 2, H. Smeets 2, P. Maffia 3, J. Kuiper 1. 1 LACDR/Leiden
University, BioTherapeutics, Leiden, The Netherlands; 2HMC Westeinde,
Surgery, Den Haag, The Netherlands; 3Centre for Immunobiology- University
of Glasgow, Immunity and Inflammation, Glasgow, United Kingdom
Background and Aims: Atherosclerosis development is enhanced by both
local and systemic immune responses and mast cells have been shown to
accumulate inside atherosclerotic plaques to promote disease progression.
Our research focused on pathways via which mast cells can elicit their
atherogenic effects and here, we aimed to analyze the interplay between
mast cells and CD4+ T-cells in atherosclerosis.
Methods: In LDLr-/- mice fed a Western-type diet (WTD), the MHC-II+/
FcεRIa+CD117+ mast cell population in the peritoneum increased signifi-
cantly (control:30.4±1.7%; WTD:52.5±5.9%, P¼0.01). To examine the effi-
cacy of the MHC-II expressing mast cells in vivo, we injected Ea-peptide
(1mg/mL), which is specifically presented by MHC-II molecules.
Results: After 24 hours, we detected Ea-peptide fragments on the peri-
toneal mast cell surface (PBS:2.3±0.2%; Ea:7.4±1.7%; P¼0.02). To further
investigate the effect of hyperlipidemia on the antigen presentation ca-
pacity of mast cells, we co-cultured OVApeptide-pretreated mast cells
under either chow orWTD serum conditions with OT-II CD4+ T-cells. CD4+
T-cell proliferation was markedly increased in the WTD condition as
measured by [3H]-Thymidine incorporation, (chow-MC: 9033±2222 dpm
compared to WTD-MC: 25332±2889 dpm, P<0.0001). Conversely, the
aortic CD4+ T cell content of mast cell deficient mice on WTD showed a
reduction in ki67+/CD4+ proliferation (apoE-/-: 30.9±5.2% vs apoE/KitW-
sh/W-sh: 13.1±1.2%; P¼0.006). Of clinical relevance, upon examination of
20 human plaques obtained by endarterectomy surgery, we observed that
18.5±4.4% of human mast cells express HLA-DR, the human equivalent of
MHC-II.
Conclusions: In conclusion, we have increasing evidence that mast cells
may function as non-classical antigen presenting cells in atherosclerosis.
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CONTINUOUS TCR SIGNALING IN THE ATHEROSCLEROTIC
ENVIRONMENT INDUCES IMMUNOMODULATORY CD8+ T-CELLS
EXPRESSING CD39
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Smeets 2, I. Bot 1, W. Jiskoot 1, J. Kuiper 1, B. Slütter 1. 1 Leiden Academic
Centre for Drug Research, Biotherapeutics, Leiden, The Netherlands;
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Abstracts / Atherosclerosis 287 (2019) e1ee21e18Background and Aims: CD8+ T-cells can be atheroprotective in clinically
relevant advanced stages of atherosclerosis, as their depletion results in
less stable lesions with a more inflammatory phenotype. However, the
phenotype and function of these cells in the lesional microenvironment
remains to be determined. Here, we address how the atherosclerotic
environment affects the functionality of CD8+ T-cells.
Methods: We compared the cytokine production of CD8+ T-cells derived
from spleens and aortas of apoE-/- mice with advanced atherosclerosis by
flow cytometry.
Results: CD8+ T-cells isolated from atherosclerotic lesions produced lower
amounts of IFN-g and TNF-a than their splenic counterparts. The observed
dysfunctional phenotype of the lesion-derived CD8+ T-cells was associated
with an increased expression of the ectonucleotidase CD39, which converts
inflammatory extracellular ATP into immunomodulatory adenosine. Indeed,
pharmacological inhibition of CD39 in apoE-/- mice partly restored cytokine
production by CD8+ T-cells. Using a bone-marrow transplantation approach,
we showed that induction of CD39 was a consequence of antigen-specific
CD8+ T-cell activation via T-cell receptor (TCR) signaling within the lesions.
Importantly, analysis of human endarterectomy samples showed a clear
microenvironment specific upregulation of CD39 on CD8+ T-cells in the pla-
ques of human patients compared to matched CD8+ T-cells from the blood .
Conclusions: Our results indicate that the continuous TCR signaling in the
atherosclerotic plaque induces an immune regulatory CD8+ T-cell
phenotype that is associated with decreased cytokine production through
increased CD39 expression in both a murine atherosclerotic model and in
atherosclerosis patients. This provides a new understanding of athero-
protective immune regulation by CD8+ T-cells.
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ENGINEERED REGULATORY T CELL ADOPTIVE THERAPY AS A NOVEL
TOOL FOR THE TREATMENT OF ATHEROSCLEROSIS
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BackgroundandAims: Loss of anti-inflammatoryactivity of Tregs has been
associated to immunoinflammatory diseases, including atherosclerosis.
Therefore, the use of Treg-Adoptive Cell Therapy(ACT) is emerging as a
therapeutic strategy to specifically modulate impaired immune responses.
Although ACT has produced encouraging results in animal models, a main
limitation remains the possibility to target a selected tissue. Our aimwas to
develop a plaque-homing selective Treg-ACT in models of atherosclerosis.
Methods: Treg were retrovirally (IRES-EGFP vector) transfected with
chemokine receptors or an empty vector and i.v. injected (2x105 GFP+
cells/mouse) in male 8-weekWTD LDLR-KO. Homing of transfected Treg to
atherosclerotic plaque, its progression and composition was analysed by
flow-cytometry and histology.
Results: The chemokine CX3CL1 is selectively expressed in the aorta, but
not in other tissues (lymph nodes, spleen and liver) of 8-week WTD LDLR-
KO, contrary to CCL2, usually associated with inflammation during
atherosclerosis. Therefore, we compared homing of CCR2- and CX3CR1-
transfected Treg to the aorta. While migration of CCR2-Treg was not se-
lective, CX3CR1-Treg showed a specific homing to atherosclerotic plaque
(p<0.05) with similar homing in lymph nodes and spleen. Next, we
investigated whether CX3CR1-Treg reduce atherosclerosis by performing
plaque analysis 4 weeks after ACT. Altough levels of plasma cholesterol
were similar, CX3CR1- vs control-Treg treated mice showed decreased
plaque area and macrophage infiltration, and increased stability(p<0.05).
Conclusions: CX3CL1/CX3CR1 axis targets selective migration to the
atherosclerotic plaque. Overexpressing CX3CR1 appears a promising ACT
to promote selective homing of Treg into the plaque thus limiting
atherosclerosis progression.Workshop track 1
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ENDOTHELIAL ATYPICAL CHEMOKINE RECEPTOR-3 IS A NOVEL DRIVER
OF ATHEROSCLEROSIS
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Background and Aims: Genome wide association studies revealed a
strong association between the CXCL12 gene locus and cardiovascular
diseases (CVD), highlighting its receptors CXCR4 and atypical chemokine
receptor-3 (ACKR3) as targets for CVD research. Although CXCR4 is well
studied in atherosclerosis, ACKR3’s particular roles remain to be expli-
cated. The aim of this project is to decipher the role of endothelial ACKR3 in
atherosclerosis.
Methods:We studied the role of endothelial ACKR3 through a knockout of
ACKR3 in the vascular endothelium (Bmx-cre) of Apolipoprotein-E defi-
cient mice fed with a cholesterol-rich diet. Lesions in the aortic roots and
arches were analyzed via hematoxylin and eosin staining. The phenotype
was further characterized using ex-vivo perfusion and intra-vital micro-
scopy for cell adhesion, Evans-blue injection for endothelial permeability,
enzyme linked immunosorbent assay and flow cytometry for inflamma-
tion assessment.
Results: Endothelial ACKR3 deficiency resulted in significantly smaller
lesion sizes in the aortic roots and arches, accompanied by more stable
plaque phenotypes (more lesional collagen and smooth muscle cell con-
tent, smaller necrotic cores). Knockout mice revealed less macrophage and
intracellular adhesion molecule (ICAM)-positive endothelial cell content
within lesions. Moreover, immune cell adhesion on carotid arteries lacking
endothelial ACKR3 was decreased whilst endothelial permeability was not
affected. Finally, knockout mice showed reduced IL-6 and classical
monocyte levels in circulation.
Conclusions: We show that endothelial ACKR3 drives atherosclerosis by
supporting leukocyte adhesion onto the endothelium and consequently
regulating intra-plaque macrophage accumulation. Endothelial ACKR3
exposes immunomodulatory properties by influencing circulating IL-6 and
classical monocyte levels. Furthermore, it plays an important role in plaque
stability.
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MYELOID INTERFERON REGULATORY FACTOR 8 DEFICIENCY PREVENTS
THE DEVELOPMENT OF ATHEROSCLEROSIS
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Background and Aims:
Background: IRF8 is a haematopoietic transcription factor crucial for the
development of myeloid cells and known to mediate their inflammatory
responses. Our group has previously shown IRF8 to selectively modulate
the expression of macrophage genes involved in atherosclerotic plaque
development.
Aim: To investigate the role of myeloid-IRF8 in atherosclerosis
development.
Methods: We have generated a myeloid-IRF8 deficient mouse model, us-
ing the LysM directed Cre recombinase, on the LDLR-deficient background
(M-IRF8KOLdlrKO). Mice were challenged with a western diet for 12 weeks
after which atherosclerotic lesions were quantified in the aortic root by
H&E staining respectively.
